Biotech
LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwired) -- 09/21/15 -- Sernova Corp. (TSX VENTURE: SVA)(FRANKFURT: PSH)(OTCQB: SEOVF), a leading clinical stage, regenerative medicine company developing biologically compat ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/21/15 -- M Pharmaceutical, Inc. (CSE: MQ)(OTCQB: MPHMF)(FRANKFURT: T3F2), (the "Company"), a clinical-stage company developing innovative ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 09/21/15 -- Theratechnologies Inc. (TSX: TH) (Theratechnologies) announced today that it will issue its financial results for the third quarter ended August 31, ...
NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 09/21/15 -- iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biopharmaceutical products, today announced further di ...
DUBLIN, IRELAND: In Vitro Potency Results Presented at 2015 ICAAC Demonstrate Advantage for VIBATIV Against Difficult-to-Treat Infections as Compared to Vancomycin, Daptomycin and Linezolid ...
SEATTLE, WA: Study to Evaluate Fulvestrant Administered With Atossa's Patented Intraductal Microcatheters; Atossa Now Has Two Phase II Clinical Programs ...
NORWOOD, MA: Study in Cystic Fibrosis Is the Third Phase 2 Clinical Trial Underway With Resunab for Treatment of Rare, Serious Inflammatory and Fibrotic Diseases ...
BOSTON, MA: BOSTON, MA -- (Marketwired) -- 09/17/15 -- announced today that the firm has been named the 2015 "Patent Strategy and Management Team of the Year" by LMG Life Sciences. The annual LMG Life ...
TORONTO, CANADA: TORONTO, CANADA -- (Marketwired) -- 09/17/15 -- Arch Biopartners Inc (Arch) or (the Company) (TSX VENTURE: ACH)(OTCBB: FOIFF) announced AB569, the Company's drug candidate for treating pulmonar ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/17/15 -- M Pharmaceutical Inc. (CSE: MQ)(OTCQB: MPHMF)(FRANKFURT: T3F2) (the "Company"), a clinical-stage company developing innovative t ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/17/15 -- Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) ("Calyx" or "the Company") is pleased to announce that its wholly-owned sub ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/16/15 -- M Pharmaceutical, Inc. (CSE: MQ)(OTCQB: MPHMF)(FRANKFURT: T3F2), (the "Company"), a clinical-stage company developing innovative ...
COLUMBUS, OH: Company to Share Results From Studies of Investigational Drug, Lasofoxifene ...
MINNEAPOLIS, MN: Healthcare Executive Brings Extensive Clinical & Public Markets Experience to Sun's Management Team ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 09/16/15 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it has effected a stock dividend on its common stock, in which each outstanding share of common ...
BOSTON, MA: BOSTON, MA -- (Marketwired) -- 09/15/15 -- announced today that five partners at the firm -- , , , , and -- have been named a 2016 Boston "Lawyer of the Year" by ®. This designation is g ...
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 09/15/15 -- Flamel Technologies (NASDAQ: FLML) today announced that the Company will be presenting at the Ladenburg Thalmann 2015 Healthcare Conference to be held at ...
MANCHESTER, NH: Interim Clinical Results of BTI-320 on Post-Prandial Hyperglycemia in High-Risk Chinese Subjects With Pre-Diabetes ...
GENEVA, SWITZERLAND: GENEVA, SWITZERLAND -- (Marketwired) -- 09/14/15 -- Novimmune, a Swiss biotech company focused on the discovery and development of antibody-based drugs for the targeted treatment of inflammatory dise ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 09/14/15 -- Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE: HEM), a clinical-stage autologous cell-therapy company, announced to ...
